Systemic inflammation in patients with COPD and pulmonary hypertension

P Joppa, D Petrasova, B Stancak, R Tkacova - Chest, 2006 - Elsevier
Study objectives COPD is a systemic disorder that is associated with increases of inflammatory
proteins in systemic circulation. However, no data on the potential role of systemic …

Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome

Z Dorkova, D Petrasova, A Molcanyiova… - Chest, 2008 - Elsevier
Background The increased risk of atherosclerotic morbidity and mortality in patients with
obstructive sleep apnea (OSA) has been linked to arterial hypertension, insulin resistance, …

[HTML][HTML] Surgical anatomy of the gastrointestinal tract and its vasculature in the laboratory rat

…, J Teleky, MZJ Elias, D Petrášová - … research and practice, 2016 - hindawi.com
The aim of this study was to describe and illustrate the morphology of the stomach, liver,
intestine, and their vasculature to support the planning of surgical therapeutic methods in …

[HTML][HTML] Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD

R Tkacova, Z Kluchova, P Joppa, D Petrasova… - Respiratory …, 2007 - Elsevier
BACKGROUND: In patients with chronic obstructive pulmonary disease (COPD), the inflammatory
processes and oxidative stress are closely linked in the lung compartment. However, …

Oxidativer Stress bei Patienten mit COPD und pulmonaler Hypertonie

P Joppa, D Petrášová, B Stančák, Z Dorková… - Wiener Klinische …, 2007 - Springer
OBJECTIVE: Oxidative stress plays an important role in the pathogenesis of chronic obstructive
pulmonary disease (COPD). Oxidant/antioxidant imbalance has also been reported in …

[HTML][HTML] Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD

P Pobeha, D Petrasova, R Tkacova, P Joppa - Respiratory Medicine, 2014 - Elsevier
Background Osteoprotegerin (OPG), a potent inhibitor of osteoclastogenesis, decreases
bone resorption and has protective effects on bone mineral density (BMD). Recently we have …

Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.

M Tajtákova, D Petrásova, J Petrovicová… - Endocrine …, 2006 - europepmc.org
Objectives To search whether there are differences in serum levels of adiponectin in subjects
with metabolic syndrome (MS) as compared to the healthy controls. Methods Serum levels …

Acute and long-term effect of infliximab on humoral and echocardiographic parameters in patients with chronic inflammatory diseases

…, M Oetterová, M Zakuciová, D Petrášová… - Clinical …, 2013 - Springer
Tumor necrosis factor alpha (TNF-alpha) plays an important role in the pathogenesis of chronic
inflammatory diseases, ie, rheumatoid arthritis (RA), ankylosing spondylitis (AS), Crohn's …

[PDF][PDF] Biomarkers associated with obesity and overweight in the Roma population residing in eastern Slovakia

D Petrásová, I Bertková, M Petrásová… - Cent Eur J Public …, 2014 - researchgate.net
Background: Obesity and overweight are major contributors to the global burden of chronic
diseases and disability in both majority and minority populations. Methods: Data from the …

[PDF][PDF] Circulating lipopolysaccharide-binding protein and carotid intima-media thickness in obstructive sleep apnea.

I Trojova, M Kozarova, D Petrasova… - Physiological …, 2018 - pdfs.semanticscholar.org
Circulating lipopolysaccharide-binding protein (LBP), a metabolic endotoxemia marker, was
identified as an independent predictor of atherosclerosis. Although increases in carotid …